We blogged about a potentially promising new treatment for Alzheimer's back in April 2008 but unfortunately, the Phase 3 clinical trials were disappointing. According to the drug makers (Wyeth and Elan), "bapineuzumab's ability to improve Alzheimer's symptoms was not significantly different from those on placebo."

A new Alzheimer's treatment has been developed called Memeron utilizing Galantamine Hydrobromide and choline alphoscerate. See http://www.memeron.com
Posted by: Doug Phillips | June 30, 2008 at 11:44 AM